Research programme: autoimmune disease therapeutics - Sigma-tauAlternative Names: Contragestazol; DL 111; DL-111-IT; ST 1959
Latest Information Update: 29 Sep 2010
At a glance
- Originator sigma-tau SpA
- Class Abortifacients; Triazoles
- Mechanism of Action Androgen receptor modulators; Cyclin modulators; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders; Cancer
Most Recent Events
- 06 Mar 2007 Preclinical trials in Autoimmune disorders in Italy (SC)